Sandbox: wdx: Difference between revisions
Jump to navigation
Jump to search
(→Do's) |
(→Do's) |
||
Line 24: | Line 24: | ||
*Administer [[Iodine-131|radioactive iodine]] therapy in patients with iodine-avid [[bone metastases]] | *Administer [[Iodine-131|radioactive iodine]] therapy in patients with iodine-avid [[bone metastases]] | ||
*Administer [[Iodine-131|radioactive iodine]] therapy in patients with [[Lung|pulmonary]] micrometastases and every 6-12 months | *Administer [[Iodine-131|radioactive iodine]] therapy in patients with [[Lung|pulmonary]] micrometastases and every 6-12 months | ||
== Don'ts == | |||
*Do not administer radioactive iodine to pregnant women | |||
*Do not administer radioactive iodine to nursing women | |||
*Do not perform surgery with focal “berry-picking” techniques |
Revision as of 20:54, 20 November 2017
Do's
Thyroglobulin level monitoring
- Order serum thyroglobulin periodically during follow-up of patients with differentiated thyroid cancer who have undergone less than total thyroidectomy
- Order serum thyroglobulin periodically during follow-up of patients with differentiated thyroid cancer who have had a total thyroidectomy but not radioactive iodine ablation
Cervical ultrasound
- Perform neck ultrasound to evaluate thyroid 6–12 months following surgery
18FDG-PET scanning
- Consider 18FDG-PET scanning in high-risk differentiated thyroid cancer patients with elevated serum thyroglobulin (generally >10 ng/mL) and negative radioactive iodine imaging
CT scans
- Order chest CT scan with or without intravenous contrast in high-risk differentiated thyroid cancer patients with elevated serum thyroglobulin (generally >10 ng/mL) or rising thyroglobulin antibodies with or without negative radioactive iodine imaging
TSH range
- Maintain serum TSH below 0.1 mU/L in patients with a structural incomplete response to therapy, indefinitely in the absence of specific contraindications
- Maintain serum TSH between 0.5-2 mU/L in patients with an excellent or indeterminate response to therapy, especially those at low risk for recurrence
Surgery for nodal disease
- Perform surgery in patients with clinically apparent, macroscopic nodal disease
- Perform therapeutic compartmental central and/or lateral neck dissection in a previously operated compartment, in patients with biopsy-proven persistent or recurrent disease for central neck nodes ≥8 mm and lateral neck nodes ≥10 mm
- Perform compartmental surgery
- Perform combination of surgery and radioactive iodine and/or external beam radiation therapy (EBRT) in patients with aerodigestive invasive disease
- Order complete blood count and assessment of renal function before administration of radioactive iodine
- Discuss preventive strategies for dental caries with patients with xerostomia
Radioactive iodine therapy
- Order pregnancy test before radioactive iodine administration
- Administer radioactive iodine therapy in patients with iodine-avid bone metastases
- Administer radioactive iodine therapy in patients with pulmonary micrometastases and every 6-12 months
Don'ts
- Do not administer radioactive iodine to pregnant women
- Do not administer radioactive iodine to nursing women
- Do not perform surgery with focal “berry-picking” techniques